Platform
Consulting
Resources
Pricing
ALS Society of Canada - ALS Canada Project Grant Program - Canada
Open

ALS Society of Canada - ALS Canada Project Grant Program

Support for innovative ALS research projects
Last Update: March 4, 2026
Funding available
No Condition
Timeline
  • Open continuously
Location
Canada

Overview

  • Information on the maximum funding amount is not available at this time.
  • This program supports ALS-related research projects, including novel approaches, ongoing ALS research programs aligned with ALS Canada’s vision, and research focused on symptom management and quality of life.
/100
Opportunity Score
Moderate potential, but conditions must align.

At a glance

Funding available

Financing goals
  • Conduct research and development activities
  • Conduct research or evaluation activities
Eligible Funding
  • No Condition
Timeline
  • Open continuously

Eligible candidates

Eligible Industries
  • All industries
Location
  • Canada
Legal structures
  • Non-profit
Annual revenue
  • All revenue ranges
Organisation size
  • All organization sizes
Audience
  • All groups
Non-profit candidates
Sector of operation
  • All industries
Target groups
  • All the groups
Revenue structures
  • All structures
Scope
  • All dimensions

Next steps

1
Determine your project
2
Validate your eligibility

Activities funded

  • Novel ALS research approaches supported by a sound rationale and a feasible experimental plan (preliminary data not necessarily required).
  • ALS research that is part of an ongoing research program and aligned with ALS Canada’s vision that “By 2024, ALS is a treatable, not terminal disease”.
  • Research focused on maximizing function, minimizing disability, and optimizing quality of life through symptom management.
  • Research supporting families and persons living with ALS.

Additional information

  • The program combines applications previously submitted under Discovery, Bridge, or Clinical Management competitions.
  • The program is intended to support projects aligned with ALS Canada’s vision that ALS becomes treatable, not terminal, by 2024.

Frequently Asked Questions about the ALS Society of Canada - ALS Canada Project Grant Program Program

Here are answers to the most common questions about the ALS Society of Canada - ALS Canada Project Grant Program. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.

What is the ALS Society of Canada - ALS Canada Project Grant Program?

Information on the maximum funding amount is not available at this time. This program supports ALS-related research projects, including novel approaches, ongoing ALS research programs aligned with ALS Canada’s vision, and research focused on symptom management and quality of life.

What expenses are eligible under ALS Society of Canada - ALS Canada Project Grant Program?

Novel ALS research approaches supported by a sound rationale and a feasible experimental plan (preliminary data not necessarily required). ALS research that is part of an ongoing research program and aligned with ALS Canada’s vision that “By 2024, ALS is a treatable, not terminal disease”. Research focused on maximizing function, minimizing disability, and optimizing quality of life through symptom management. Research supporting families and persons living with ALS.

Who can I contact for more information about the ALS Society of Canada - ALS Canada Project Grant Program?

You can contact Novartis Pharmaceuticals Canada Inc..

Where is the ALS Society of Canada - ALS Canada Project Grant Program available?

The ALS Society of Canada - ALS Canada Project Grant Program program is available across Canada.

Is the ALS Society of Canada - ALS Canada Project Grant Program a grant, loan, or tax credit?

ALS Society of Canada - ALS Canada Project Grant Program is a Grant and Funding

Who are the financial supporters of the ALS Society of Canada - ALS Canada Project Grant Program?

ALS Society of Canada - ALS Canada Project Grant Program is funded by Novartis Pharmaceuticals Canada Inc.